Vixiar Medical, Inc. — Form D
Vixiar Medical, Inc. of Annapolis, MD, a company, filed a Form D exempt-offering notice with the SEC on 2018-03-16. The offering totals $1.8M, of which $1.6M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2018-03-16
- Form: D
- Accession: 0001589946-18-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.8M
- Amount sold: $1.6M
- Remaining: $235K
- Minimum investment: $20K
- Investors: 5
- Date of first sale: 2017-09-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-307946
Issuer
- Name: Vixiar Medical, Inc.
- CIK: 0001589946
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 91 Main Street, Annapolis, MD, 21401
- Phone: 443-306-7616
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| R. CALVIN GOFORTH | Director | FAYETTEVILLE, AR |
| Bob Calvin Storey | Director | Annapolis, MD |
| Kevin Thibodeau | Director | Annapolis, MD |
| Kevin Thibodeau | Executive Officer | Annapolis, MD |
| Robert Calvin Goforth | Director | Fayetteville, AR |
| Robert Storey | Director | Arnold, MD |
| Robert Storey | Executive Officer | Arnold, MD |
| Mark Calvin Kidd | Executive Officer | Fayetteville, AR |
Other filings by this issuer (1)
More